IDRA insider filings

IDERA PHARMACEUTICALS, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-01-12. Screen IDRA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for IDRA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — IDERA PHARMACEUTICALS, INC.

FiledFormInsiderReported transactionsSource
2023-01-124DOUGHERTY MICHAEL R — DirectorGrant/award (A): 33,523 @ $0.44EDGAR
2023-01-104Lim Bryant David — SVP AND GENERAL COUNSELGrant/award (A): 399,218 @ $0 · Tax withholding (F): 119,957 @ $0.71EDGAR
2023-01-104Kirby John J. — CHIEF FINANCIAL OFFICERGrant/award (A): 399,218 @ $0 · Tax withholding (F): 119,957 @ $0.71EDGAR
2023-01-104JORDAN ANDREW R — CHIEF STRATEGY OFFICERGrant/award (A): 261,718 @ $0 · Tax withholding (F): 73,940 @ $0.71EDGAR
2022-10-054DOUGHERTY MICHAEL R — DirectorGrant/award (A): 58,516 @ $0.37EDGAR
2022-10-034NovaQuest Co-Investment Fund XV, L.P. — Director
NQ POF V GP, Ltd. — Director
Other (J): 5 · Other (J): 1,343,547 (derivative) · Other (J): 14,115 (derivative) · Other (J): 14,115 (derivative)EDGAR
2022-09-304Taylor John Clayton — Chief Executive Officer, DirectorGrant/award (A): 2,171,214 · Grant/award (A): 22,810 (derivative)EDGAR
2022-09-304Kraus Carl N — Chief Medical OfficerGrant/award (A): 651,364 (derivative) · Grant/award (A): 6,843 (derivative) · Grant/award (A): 6,843 (derivative)EDGAR
2022-09-304Salain Daniel — Chief Operating OfficerGrant/award (A): 2,171,214 · Grant/award (A): 22,810 (derivative)EDGAR
2022-09-304WOOTEN RONALD J — DirectorOther (J): 5 · Other (J): 1,343,547 (derivative) · Other (J): 14,115 (derivative) · Other (J): 14,115 (derivative)EDGAR
2022-09-304JORDAN ANDREW R — Chief Strategy OfficerGrant/award (A): 651,364 · Grant/award (A): 6,843 (derivative)EDGAR
2022-09-264Pillar Invest Corp — 10% owner
Pillar Partners Foundation, L.P. — 10% owner
Pillar Pharmaceuticals 6, L.P. — 10% owner
Umari Abude — 10% owner
ZEIN YOUSSEF EL — 10% owner
Option exercise/expiry (X): 1,533,159 @ $0.01 · Option exercise/expiry (X): 1,533,159 (derivative) @ $0EDGAR
2022-07-074Lim Bryant David — SVP AND GENERAL COUNSELGrant/award (A): 66,500 (derivative) @ $0EDGAR
2022-07-074Kirby John J. — CHIEF FINANCIAL OFFICERGrant/award (A): 66,500 (derivative) @ $0EDGAR
2022-07-074SOLAND DANIEL B — CHIEF OPERATING OFFICERGrant/award (A): 66,500 (derivative) @ $0EDGAR
2022-07-074MILANO VINCENT — PRESIDENT AND CEO, DirectorGrant/award (A): 124,000 (derivative) @ $0EDGAR
2022-07-064DOUGHERTY MICHAEL R — DirectorGrant/award (A): 50,086 @ $0.44EDGAR
2022-06-274Goldberg Mark Alan — DirectorGrant/award (A): 26,000 (derivative) @ $0EDGAR
2022-06-274Csimma Cristina — DirectorGrant/award (A): 26,000 (derivative) @ $0EDGAR
2022-06-274GOWEN MAXINE — DirectorGrant/award (A): 26,000 (derivative) @ $0EDGAR
2022-06-274SCHAFER CAROL — DirectorGrant/award (A): 26,000 (derivative) @ $0EDGAR
2022-06-274GERAGHTY JAMES A — DirectorGrant/award (A): 26,000 (derivative) @ $0EDGAR
2022-06-274DOUGHERTY MICHAEL R — DirectorGrant/award (A): 26,000 (derivative) @ $0EDGAR
2022-04-054DOUGHERTY MICHAEL R — DirectorGrant/award (A): 41,155 @ $0.54EDGAR
2022-04-044Lim Bryant David — SVP AND GENERAL COUNSELGrant/award (A): 41,500 (derivative) @ $0EDGAR
2022-04-044Kirby John J. — CHIEF FINANCIAL OFFICERGrant/award (A): 41,500 (derivative) @ $0EDGAR
2022-04-044SOLAND DANIEL B — CHIEF OPERATING OFFICERGrant/award (A): 41,500 (derivative) @ $0EDGAR
2022-04-044MILANO VINCENT — PRESIDENT AND CEO, DirectorGrant/award (A): 99,000 (derivative) @ $0EDGAR
2022-01-264Lim Bryant David — SVP AND GENERAL COUNSELGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-01-264Kirby John J. — CHIEF FINANCIAL OFFICERGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-01-264SOLAND DANIEL B — CHIEF OPERATING OFFICERGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-01-264MILANO VINCENT — PRESIDENT AND CEO, DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-01-054DOUGHERTY MICHAEL R — DirectorGrant/award (A): 37,062 @ $0.59EDGAR
2021-12-214Kirby John J. — CHIEF FINANCIAL OFFICERPurchase (P): 10,000 @ $0.61EDGAR
2021-10-044DOUGHERTY MICHAEL R — DirectorGrant/award (A): 21,229 @ $1.03EDGAR
2021-07-124Lim Bryant David — SVP AND GENERAL COUNSELGrant/award (A): 66,500 (derivative) @ $0EDGAR
2021-07-124Kirby John J. — CHIEF FINANCIAL OFFICERGrant/award (A): 66,500 (derivative) @ $0EDGAR
2021-07-124SOLAND DANIEL B — CHIEF OPERATING OFFICERGrant/award (A): 66,500 (derivative) @ $0EDGAR
2021-07-124MILANO VINCENT — PRESIDENT AND CEO, DirectorGrant/award (A): 124,000 (derivative) @ $0EDGAR
2021-06-214SOLAND DANIEL B — CHIEF OPERATING OFFICERPurchase (P): 50,000 @ $1.19EDGAR
2021-06-104Goldberg Mark Alan — DirectorGrant/award (A): 26,000 (derivative) @ $0EDGAR
2021-06-104Csimma Cristina — DirectorGrant/award (A): 26,000 (derivative) @ $0EDGAR
2021-06-104GOWEN MAXINE — DirectorGrant/award (A): 26,000 (derivative) @ $0EDGAR
2021-06-104SCHAFER CAROL — DirectorGrant/award (A): 26,000 (derivative) @ $0EDGAR
2021-06-104GERAGHTY JAMES A — DirectorGrant/award (A): 26,000 (derivative) @ $0EDGAR
2021-06-104DOUGHERTY MICHAEL R — DirectorGrant/award (A): 26,000 (derivative) @ $0EDGAR
2021-06-034DOUGHERTY MICHAEL R — DirectorPurchase (P): 85,000 @ $1.19EDGAR
2021-04-294/APillar Invest Corp — 10% owner
Pillar Partners Foundation, L.P. — 10% owner
Pillar Pharmaceuticals 6, L.P. — 10% owner
Umari Abude — 10% owner
ZEIN YOUSSEF EL — 10% owner
Option exercise/expiry (X): 1,612,196 @ $0.01 · Option exercise/expiry (X): 883,613 @ $0.01 · Option exercise/expiry (X): 1,612,196 (derivative) @ $0.01 · Option exercise/expiry (X): 883,613 (derivative) @ $0.01EDGAR
2021-04-054GERAGHTY JAMES A — DirectorGrant/award (A): 14,773 @ $1.32EDGAR
2021-04-054DOUGHERTY MICHAEL R — DirectorGrant/award (A): 10,939 @ $1.32EDGAR

Recent 8-K events — IDERA PHARMACEUTICALS, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-08-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-07-218-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-07-118-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-308-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-048-K?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
EDGAR
2023-03-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-02-068-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-038-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-188-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-178-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=IDRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs